BVXV Annual Total Liabilities
$28.83 M
-$2.23 M-7.17%
31 December 2022
Summary:
As of January 26, 2025, BVXV annual total liabilities is $28.83 million, with the most recent change of -$2.23 million (-7.17%) on December 31, 2022. During the last 3 years, it has fallen by -$23.39 million (-44.79%).BVXV Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Quarterly Total Liabilities
$27.01 M
-$1.09 M-3.89%
30 June 2023
Summary:
As of January 26, 2025, BVXV quarterly total liabilities is $27.01 million, with the most recent change of -$1.09 million (-3.89%) on June 30, 2023. Over the past year, it has increased by +$3.65 million (+15.63%).BVXV Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.2% | +15.6% |
| 3 y3 years | -44.8% | -36.9% |
| 5 y5 years | +293.8% | +123.8% |
BVXV Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -44.8% | -48.3% |
BiondVax Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $27.01 M(-3.9%) |
| Mar 2023 | - | $28.10 M(-2.5%) |
| Dec 2022 | $28.83 M(-7.2%) | $28.83 M(+57.2%) |
| Sept 2022 | - | $18.34 M(-21.5%) |
| June 2022 | - | $23.36 M(-6.4%) |
| Mar 2022 | - | $24.95 M(-19.7%) |
| Dec 2021 | $31.05 M(+39.6%) | $31.05 M(+30.1%) |
| Sept 2021 | - | $23.86 M(+1.3%) |
| June 2021 | - | $23.55 M(+6.4%) |
| Mar 2021 | - | $22.14 M(-0.5%) |
| Dec 2020 | $22.24 M(-57.4%) | $22.24 M(-0.1%) |
| Sept 2020 | - | $22.26 M(-48.0%) |
| June 2020 | - | $42.83 M(-18.0%) |
| Dec 2019 | $52.21 M(+43.5%) | $52.21 M(+30.1%) |
| Sept 2019 | - | $40.12 M(-3.3%) |
| June 2019 | - | $41.49 M(+15.8%) |
| Mar 2019 | - | $35.82 M(-1.6%) |
| Dec 2018 | $36.39 M | $36.39 M(+98.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $18.34 M(+51.9%) |
| June 2018 | - | $12.07 M(+41.6%) |
| Mar 2018 | - | $8.53 M(+16.5%) |
| Dec 2017 | $7.32 M(+526.6%) | $7.32 M(+71.7%) |
| Sept 2017 | - | $4.26 M(-26.3%) |
| June 2017 | - | $5.78 M(+71.7%) |
| Mar 2017 | - | $3.37 M(+188.2%) |
| Dec 2016 | $1.17 M(-41.2%) | $1.17 M(-3.5%) |
| Sept 2016 | - | $1.21 M(-24.1%) |
| June 2016 | - | $1.59 M(-2.5%) |
| Mar 2016 | - | $1.64 M(-17.8%) |
| Dec 2015 | $1.99 M(+313.0%) | $1.99 M(-5.4%) |
| Sept 2015 | - | $2.10 M(-16.3%) |
| June 2015 | - | $2.51 M(+484.9%) |
| Mar 2015 | - | $429.10 K(-10.9%) |
| Dec 2014 | $481.50 K(-8.7%) | $481.50 K(+17.1%) |
| Sept 2014 | - | $411.10 K(-22.1%) |
| Dec 2013 | $527.50 K(+93.8%) | $527.50 K |
| Dec 2012 | $272.20 K | - |
FAQ
- What is BiondVax Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual total liabilities year-on-year change?
- What is BiondVax Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly total liabilities year-on-year change?
What is BiondVax Pharmaceuticals annual total liabilities?
The current annual total liabilities of BVXV is $28.83 M
What is the all time high annual total liabilities for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual total liabilities is $52.21 M
What is BiondVax Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, BVXV annual total liabilities has changed by -$2.23 M (-7.17%)
What is BiondVax Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of BVXV is $27.01 M
What is the all time high quarterly total liabilities for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly total liabilities is $52.21 M
What is BiondVax Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, BVXV quarterly total liabilities has changed by +$3.65 M (+15.63%)